Literature DB >> 15509516

Roles and regulation of stat family transcription factors in human breast cancer.

Charles V Clevenger1.   

Abstract

Stats (for signal transducers and activators of transcription) are a family of transcription factors that regulate cell growth and differentiation. Their activity is latent until phosphorylation by receptor-associated kinases. A sizable body of data from cell lines, mouse models, and human tissues now implicates these transcription factors in the oncogenesis of breast cancer. Because Stat activity is modulated by several posttranslational modifications and protein-protein interactions, these transcription factors are capable of integrating inputs from multiple signaling networks. Given this, the future utilization of Stats as prognostic markers and therapeutic targets in human breast cancer appears likely.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15509516      PMCID: PMC1618660          DOI: 10.1016/S0002-9440(10)63403-7

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  112 in total

1.  Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor.

Authors:  C Schindler; K Shuai; V R Prezioso; J E Darnell
Journal:  Science       Date:  1992-08-07       Impact factor: 47.728

2.  Identification of the immunophilins capable of mediating inhibition of signal transduction by cyclosporin A and FK506: roles of calcineurin binding and cellular location.

Authors:  R J Bram; D T Hung; P K Martin; S L Schreiber; G R Crabtree
Journal:  Mol Cell Biol       Date:  1993-08       Impact factor: 4.272

3.  A common nuclear signal transduction pathway activated by growth factor and cytokine receptors.

Authors:  H B Sadowski; K Shuai; J E Darnell; M Z Gilman
Journal:  Science       Date:  1993-09-24       Impact factor: 47.728

Review 4.  Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins.

Authors:  J E Darnell; I M Kerr; G R Stark
Journal:  Science       Date:  1994-06-03       Impact factor: 47.728

5.  A single phosphotyrosine residue of Stat91 required for gene activation by interferon-gamma.

Authors:  K Shuai; G R Stark; I M Kerr; J E Darnell
Journal:  Science       Date:  1993-09-24       Impact factor: 47.728

6.  Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6.

Authors:  Z Zhong; Z Wen; J E Darnell
Journal:  Science       Date:  1994-04-01       Impact factor: 47.728

7.  JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin.

Authors:  B A Witthuhn; F W Quelle; O Silvennoinen; T Yi; B Tang; O Miura; J N Ihle
Journal:  Cell       Date:  1993-07-30       Impact factor: 41.582

8.  Structure of the murine Jak2 protein-tyrosine kinase and its role in interleukin 3 signal transduction.

Authors:  O Silvennoinen; B A Witthuhn; F W Quelle; J L Cleveland; T Yi; J N Ihle
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

9.  Receptor-mediated nuclear translocation of growth hormone.

Authors:  P E Lobie; H Mertani; G Morel; O Morales-Bustos; G Norstedt; M J Waters
Journal:  J Biol Chem       Date:  1994-08-19       Impact factor: 5.157

10.  Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response.

Authors:  H Wakao; F Gouilleux; B Groner
Journal:  EMBO J       Date:  1994-05-01       Impact factor: 11.598

View more
  74 in total

Review 1.  The biological functions of the versatile transcription factors STAT3 and STAT5 and new strategies for their targeted inhibition.

Authors:  Sylvane Desrivières; Christian Kunz; Itamar Barash; Vida Vafaizadeh; Corina Borghouts; Bernd Groner
Journal:  J Mammary Gland Biol Neoplasia       Date:  2006-01       Impact factor: 2.673

2.  Bortezomib induces apoptosis and growth suppression in human medulloblastoma cells, associated with inhibition of AKT and NF-ĸB signaling, and synergizes with an ERK inhibitor.

Authors:  Fan Yang; Veronica Jove; Shirley Chang; Michael Hedvat; Lucy Liu; Ralf Buettner; Yan Tian; Anna Scuto; Wei Wen; M L Richard Yip; Timothy Van Meter; Yun Yen; Richard Jove
Journal:  Cancer Biol Ther       Date:  2012-04-01       Impact factor: 4.742

3.  HMGN2 inducibly binds a novel transactivation domain in nuclear PRLr to coordinate Stat5a-mediated transcription.

Authors:  Alyson A Fiorillo; Terry R Medler; Yvonne B Feeney; Yi Liu; Kalie L Tommerdahl; Charles V Clevenger
Journal:  Mol Endocrinol       Date:  2011-08-04

4.  CanProVar: a human cancer proteome variation database.

Authors:  Jing Li; Dexter T Duncan; Bing Zhang
Journal:  Hum Mutat       Date:  2010-03       Impact factor: 4.878

5.  Signal transducers and activators of transcription-3 up-regulates tissue inhibitor of metalloproteinase-1 expression and decreases invasiveness of breast cancer.

Authors:  Jennifer Dien; Hesham M Amin; Neil Chiu; Winson Wong; Christine Frantz; Brian Chiu; John R Mackey; Raymond Lai
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

6.  STAT3 and STAT5b polymorphism contributes to breast cancer risk and clinical outcomes.

Authors:  Ling Zhao; Qingyuan Zhang; Xin Luan; Xu Huang; Shu Zhao; Hong Zhao
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

7.  Anticancer efficacy of a difluorodiarylidenyl piperidone (HO-3867) in human ovarian cancer cells and tumor xenografts.

Authors:  Karuppaiyah Selvendiran; Liyue Tong; Anna Bratasz; M Lakshmi Kuppusamy; Shabnam Ahmed; Yazhini Ravi; Nancy J Trigg; Brian K Rivera; Tamás Kálai; Kálmán Hideg; Periannan Kuppusamy
Journal:  Mol Cancer Ther       Date:  2010-05-04       Impact factor: 6.261

8.  STAT3 genetic variant, alone and in combination with STAT5b polymorphism, contributes to breast cancer risk and clinical outcomes.

Authors:  Haishan Zhao; Zhe Wang; Huizhe Wu; Qinghuan Xiao; Weifan Yao; Enhua Wang; Yong Liu; Minjie Wei
Journal:  Med Oncol       Date:  2014-12-07       Impact factor: 3.064

9.  Green tea catechins inhibit angiogenesis through suppression of STAT3 activation.

Authors:  Hoyee Leong; Priya S Mathur; Geoffrey L Greene
Journal:  Breast Cancer Res Treat       Date:  2008-09-28       Impact factor: 4.872

10.  Avicin D: a protein reactive plant isoprenoid dephosphorylates Stat 3 by regulating both kinase and phosphatase activities.

Authors:  Valsala Haridas; Goshi Nishimura; Zhi-Xiang Xu; Fiona Connolly; Margaret Hanausek; Zbigniew Walaszek; Robert Zoltaszek; Jordan U Gutterman
Journal:  PLoS One       Date:  2009-05-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.